Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Decreases By 17.1%

Cellebrite DI Ltd. (NASDAQ:CLBT) was the target of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 1,450,000 shares, a decrease of 17.1% from the November 15th total of 1,750,000 shares. Currently, 1.7% of the shares of the stock are sold short. Based on an average daily volume of 1,300,000 shares, the short-interest ratio is presently 1.1 days.

Institutional Trading of Cellebrite DI

A number of large investors have recently bought and sold shares of the business. Quarry LP acquired a new stake in shares of Cellebrite DI during the 3rd quarter worth approximately $27,000. Point72 Asia Singapore Pte. Ltd. boosted its stake in Cellebrite DI by 59.6% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock worth $33,000 after acquiring an additional 1,017 shares in the last quarter. Advisors Asset Management Inc. grew its holdings in Cellebrite DI by 130.5% in the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock worth $52,000 after purchasing an additional 1,742 shares during the period. Public Employees Retirement Association of Colorado bought a new stake in Cellebrite DI in the second quarter valued at $71,000. Finally, Pathway Financial Advisers LLC raised its holdings in shares of Cellebrite DI by 1,583.8% during the third quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company’s stock valued at $74,000 after purchasing an additional 4,118 shares during the period. 45.88% of the stock is currently owned by institutional investors and hedge funds.

Cellebrite DI Stock Performance

Shares of CLBT traded up $0.41 during mid-day trading on Monday, reaching $20.29. 571,074 shares of the company were exchanged, compared to its average volume of 1,178,313. The business has a 50 day simple moving average of $18.93 and a two-hundred day simple moving average of $15.82. Cellebrite DI has a 52 week low of $7.91 and a 52 week high of $21.72. The stock has a market capitalization of $4.18 billion, a PE ratio of -12.83, a PEG ratio of 2.71 and a beta of 1.51.

Cellebrite DI (NASDAQ:CLBT) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The firm had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. During the same quarter in the previous year, the company earned $0.09 EPS. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, analysts predict that Cellebrite DI will post 0.32 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CLBT. JPMorgan Chase & Co. boosted their target price on shares of Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Monday. TD Cowen boosted their price objective on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. Craig Hallum increased their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, Needham & Company LLC boosted their price target on Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cellebrite DI has a consensus rating of “Buy” and a consensus price target of $20.57.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.